Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. tVNS is safe for children and approved for pediatric use. tVNS provides benefits in mental development and motor development. Use of tVNS® in Children tVNS is safe for children and MDR CE approved for pediatric use Epilepsy, Autism, Prader Willy Syndrom are the approved indications Young children should use the device under parental supervision. Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. Reducing drug use helps prevent the side effects of anti-epileptic drugs Improves energy, concentration, and mood Children who are using the therapy in the long term can experience cognitive and motor improvement

Non-surgical, drug-free, low side-effect treatment for tVNS migraine. The most up-to-date health information about migraine causes, symptoms, treatment options Migraines Migraines manifest as a neurological disorder characterized by an intense, pulsating headache, frequently concentrated on one side of the head. Unique features setting migraines apart from other headaches include nausea, vomiting, and heightened sensitivity to sound and light. The intensity of the pain often hinders the performance of daily tasks, resulting in limitations. Notably, migraine attacks stand as a primary contributor to disability and work-related absence in developed nations Less migraines - more from life. Treatment Options for Migraines Acupuncture Treatment One of the most commonly used treatment methods for migraine treatment in western countries is acupuncture. Acupuncture has the ability to increase the release of endorphins in the body which act as powerful pain relievers. At the same time, acupuncture also activates calming chemicals in the body. Botulinum Toxin Treatment Another treatment method in chronic migraine patients is botulinum toxin treatment, which has been applied since 2010. The frequency and severity of pain can be reduced by applying it to patients who use too many painkillers and are unresponsive to other treatments. This treatment is generally well tolerated and there are no serious side effects. Dry Needle Therapy Dry needle therapy is a drug-free, scientific treatment method based on the stimulation of the trigger points in the muscles in different parts of the body using special needles of different sizes. Migraine Surgery Migraine surgery is the intervention of the nerve branches located in the forehead, temples, neck and nape root of the migraine-related regions of the brain, and to the vessels and muscles around these nerve branches. With surgery, these anatomical structures may be permanently damaged, nerve endings may be damaged and ‘neuropathic pains’ may occur. Anti-CGRP Injection CGRP plays a key role in dilating or widening blood vessels. The injection works to block the sites in and around the brain in place of CRGP or binds directly to CGRP and prevents it from being effective. The effects are not yet known. Medications that lower CRGP may cause side effects that affect your blood pressure and heart. Transcutaneous Vagus Nerve Stimulation The tVNS® auricular vagus stimulation device is a treatment option that provides vagus nerve stimulation through the ear with a smartphone-sized device and a special headset without any surgical intervention. How does tVNS® treat migraines? The focus of migraine therapy with tVNS® is the activation of the parasympathetic part of the autonomic nervous system. This part of the nervous system is always active when we are relaxing or resting and is responsible for cell regeneration and metabolic processes. The stimulation of the parasympathetic nervous system triggers the necessary regeneration processes of inflammatory areas and acts as a recovery accelerator. Neurostimulation with tVNS® is used both as a migraine prophylaxis and during an acute attack. While drugs are taken orally and thus develop their effect systematically, they are often accompanied by numerous undesirable side effects. Therapy with tVNS® , on the other hand, has the advantage that it activates the parasympathetic system directly by stimulating the vagus nerve on the ear and has very few side effects. tVNS® has helped hundreds of patients suffering from migraines to reduce or completely eliminate migraines and lead a more self-determined life. “The idea of treating migraine without medication appealed to me immediately. And now, a year and a half after the first application, I have a completely new quality of life.” M. Dohring from Berlin Contact Us

TVNS treatment in Crohn's disease. The most up-to-date health information on crohn's disease causes, symptoms, treatment options Crohn's Disease Groundbreaking Technologies for Life What is Crohn's Disease ? Crohn's disease is a type of inflammatory bowel disease that causes inflammation of the gastrointestinal tract from the mouth to the anus. This inflammation can be attached to one or more parts of the digestive system, but it is usually seen in the ileum, which is the last part of the small intestine, and in the beginning of the large intestine. Crohn's disease can cause inflammation in your digestive tract, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. Growth-development retardation in children may be signs of Crohn's disease. Extra-intestinal diseases are also observed in a quarter of Crohn's patients. These mostly occur in the skin, joints, eyes, liver and biliary tract, kidney and urinary tract, vascular heart and lungs. Crohn's Disease Symptoms Diarrhea Abdominal pains Intestinal blockages Fever Fatigue Loss of appetite and weight loss Still feeling full after using the toilet Frequent toileting is one of the early symptoms of Crohn's disease. Insomnia Tanı Yöntemleri Crohn's Disease Causes Immune system: It is possible for a virus or bacteria to trigger Crohn's disease; however, scientists have yet to identify such a trigger. When your immune system tries to fight off the invading microorganism, an abnormal immune response can cause the immune system to attack cells in the digestive tract as well. Heredity: Crohn's disease is more common in people with a family history of the same disease, so genes may play a role in the occurrence of the disease. Crohn's Disease Diagnostic Methods Blood analysis Stool analysis Stomach, small and large intestine films Colonoscopy and endoscopy CT and MRI images Crohn's disease can occur at any age, but it usually occurs when the disease is young. Most people who develop Crohn's disease are diagnosed before they reach the age of about 30. You are at higher risk for the disease if you have a first-degree relative with the disease, such as a parent, sibling, or child. About 1 in 5 people with Crohn's disease have a family member with the disease. Facts About Crohn's Disease Treatment Options for Crohn's Disease Medication Steroid drugs: These are drugs to reduce inflammation in the digestive system. Drugs for the immune system: These are drugs used to control the immune system. More information Surgical treatment Most Crohn's Disease patients may need surgical treatment. Removing the problematic parts of the digestive system and reconnecting them to healthy parts is the aim of surgical treatment. More information Crohn's Disease Diet In general, the patient is given a high-energy, abundant protein, low-fiber, low-fat diet rich in vitamins and minerals. For some patients, consumption of milk and dairy products is prohibited. More information Transcutaneous Vagus Nerve Stimulation (tVNS) tVNS ® reduces inflammation in the intestine, allowing the intestine to do its job more healthily. More information Contact us

Pioneering Neuromodulation Research with tVNS® Discover why tVNS® is the preferred device for research on transcutaneous vagus nerve stimulation.With its precise cymba concha stimulation and wireless parameter flexibility, tVNS offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols.Approved under the EU-MDR and backed by CB reports, our tVNS device ensures adherence to the highest standards of safety and efficacy in medical research. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why We Lead in Vagus Nerve Stimulation? For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Learn More About tVNS Health GmbH Why Choose our tVNS® Devices for Research? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. Introducing the tVNS® Triggerbox Launching December 1, 2024, the tVNS® Triggerbox advances neuromodulation research by providing a cable-bound system that minimizes latencies and enhances protocol reproducibility. This key advancement ensures precise, reliable experimental setups for cutting-edge studies. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® E device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. The supporting comprehensive CB reports not only highlight our device’s safety and efficacy but also facilitate smoother approval processes for your research protocols by ethics committees. EU-MDR Cla ss IIa Cymba Concha Stimulation Benefit from our device’s electrode design, targeting the cymba concha, a method preferred by researchers for its 100% innervation of the auricular branch of the vagus nerve (ABVN). This targeted approach is designed to maximize therapeutic outcomes by engaging the vagus nerve more effectively than other non-invasive methods. EU-MDR Cla ss IIa Wireless Connectivity and Programmability Leverage the power of wireless technology for seamless operation and data management. The tVNS® Research app enables remote programming of stimulation parameters, providing the flexibility needed to adapt to the evolving needs of complex research protocols without interrupting the participant’s experience. EU-MDR Cla ss IIa Made in Germany Trust in the quality and reliability of a device that’s proudly designed and manufactured in Germany. Our commitment to excellence guarantees that every tVNS® device meets the highest standards of performance, durability, and safety, making it the ideal choice for institutions demanding the best in research equipment. EU-MDR Cla ss IIa Titanium-Iridium Electrode Our tVNS® device features titanium-iridium electrodes, most often used in implants and known for their biocompatibility, offering optimal stimulation with minimal irritation. This superior choice sets us apart from stainless steel alternatives, ensuring a more comfortable and effective treatment experience. EU-MDR Cla ss IIa GDPR-Compliant Data Processing With a commitment to privacy and security, our tVNS® system ensures that all data collected through the app is processed in strict adherence to the General Data Protection Regulation (GDPR). Researchers can collect, store, and analyze sensitive data with confidence, knowing that participant privacy is protected. EU-MDR Cla ss IIa Global Network of Trusted Institutions Join an esteemed community of researchers from leading universities and hospitals around the world who have chosen tVNS® for their studies in the global effort to advance neurological research and patient care. EU-MDR Cla ss IIa 20+ Years of Experience With over 20 years of dedicated research and development, we proudly developed the world's first approved non-invasive vagus nerve stimulator, the Cerbomed Nemos® device. Our deep-rooted expertise and pioneering spirit have established us as leaders in the field, committed to delivering groundbreaking and effective solutions for our patients. tVNS® for Research: An Overview Welcome to the frontier of vagus nerve stimulation research. Our tVNS® R device is designed for flexibility and precision, offering full wireless programmability for comprehensive clinical studies. With the tVNS® Research and tVNS® Patient apps, adjustment of stimulation parameters, data collection and patient feedback are seamlessly integrated, enhancing the scope and accuracy of your research. We are committed to facilitating your clinical trials and provide support for studies, including a comprehensive CB safety report for ethics approvals and access to a global network of experts. Explore the potential of tVNS® R to forge new paths in neurological research and patient care. Full Wireless Parameter Programmability and Triggered tVNS® With the tVNS® Research app, you have the capability to wirelessly adjust a comprehensive range of parameters including frequency, pulse width, current intensity, and stimulation intervals. In addition, we offer a separate PC-based tVNS® manager software. This software enables reaction to outside trigger signals (e.g. ECG R-wave trigger generated by an external ECG system, transferred to a PC). Thus, closed loop tVNS® or triggered tVNS® can be realized in a scientific setup. Precision in Research with the tVNS® Triggerbox The new tVNS® Triggerbox, launching December 1, 2024, marks a significant advancement in the field of tVNS® research. Designed in response to feedback from scientific communities, this device addresses the crucial need for more stable and reproducible stimulation protocols in tVNS®. By replacing Bluetooth connections with a cable-bound system, the tVNS® Triggerbox significantly reduces latencies and fluctuations, enabling precise synchronization with external trigger signals. This innovation not only enhances the reliability of experimental setups but also simplifies the integration with existing research frameworks, promising to push the boundaries of tVNS® research further. Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Customization and Support for Trials We offer an individual adaptation of all components of the device for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Legacy and Hook Electrode We offer two different types of electrode designs with our tVNS® devices: The Hook Electrode (left) allows for better fixation and usability during active tasks. It also allows patients to wear earphones. The Legacy Electrode (right) can be used if the patient has small ears or a special ear shape. The integrated slider allows for better adaption to the ear. Sham and fMRI Electrode Options The well-known sham-stimulation option at the earlobe is possible with our Legacy Electrode. Upon request, we also provide more sophisticated sham-stimulation options, as well as fMRI-compatible electrodes. Support for Clinical Trials We offer an individual adaptation of all parts for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Book a Personal Consultation with our Research Experts Contact our tVNS® Research Team to learn more about tVNS® and receive personalized information and support, such as CB Reports and Instructions for Use (IFU). Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. About Us tVNS Health Gmbh is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients' quality of life. Meet the Founders Berkay Gezen is an enthusiastic professional with 28+ global business development and medical brand management. He has served as the global commercial director of CardiAid, brand for 11 years, from the design of the brand to its expansion in over 65 countries of the world. Following his creative vision of AED and his experience in global development, he became the founder of tVNS Health to focus on neuromodulation and vagus nerve stimulation technologies, sales, services and distribution for tVNS. With his expertise in market building, he become the implementer of projects that make a difference in more than 80 countries of the world. He has dedicated his professional life to increasing the awareness of public access defibrillators and neuromodulation. With his motivation, he inspires the medical community and continues to manage medical channel in more than 50 countries worldwide. Berkay Gezen Selin Erdogan Gezen She is a visionary leader in the field of neuromodulation technologies and global business development. After pivotal roles in renowned companies like Vodafone, Garanti BBVA Bank, and Hewlett Packard, as program management in innovative technology projects, Selin embarked on a new chapter as a founding partner of Nervovita Medical Technologies and tVNS Health, focusing on neuromodulation therapies. Her dedication led to the accessibility of transcutaneous vagal nerve stimulation, revolutionizing treatment options around the globe. She collaborates with leading universities and institutes in over 40 countries, driving clinical studies across various diseases. She is designing the human-machine interaction for better usability of wearable medical devices. "Our mission is to empower individuals worldwide with innovative neuromodulation and bio-electronic solutions that enhance well-being and improve lives. Committed to advancing healthcare through cutting-edge technology, we strive to be the global leader in distributing the transcutaneous vagus nerve stimulation devices. Guided by a dedication to excellence, integrity, and social responsibility, our company aims to establish a pervasive presence in the global market, ensuring accessibility to the transformative benefits of the tVNS devices. We are driven by a passion for improving mental and physical health, fostering a world where individuals can achieve their full potential and lead fulfilling lives. Our commitment extends beyond the distribution; we aim to build enduring partnerships with healthcare professionals, research institutions, and distributors to foster a collaborative ecosystem. By prioritizing customer satisfaction, continuous innovation, and ethical business practices, we aim to create a positive impact on the well-being of communities around the globe." Our Mission Our Vision "We envision a future where transformative neuromodulation technology becomes an integral part of global healthcare, revolutionizing the way individuals manage and enhance their well-being. Guided by innovation, compassion, and a commitment to excellence, we aspire to establish ourselves as the foremost global influence, ensuring universal access, recognition, and trust in the widespread expansion of transcutaneous vagus nerve stimulation technologies (taVNS). We aspire to lead the charge in advancing the field of neuromodulation, continuously pushing the boundaries of what is possible to unlock the full potential of the human body's innate healing mechanisms. By fostering a culture of curiosity, collaboration, and inclusivity, we aim to inspire a global movement toward proactive and personalized healthcare solutions. Through strategic partnerships, ongoing research, and a commitment to ethical business practices, we seek to shape a healthcare landscape where preventative and holistic approaches are celebrated. As we strive for excellence, our vision extends beyond business success to contributing significantly to the betterment of society. We see a world where the neuromodulation becomes a beacon of hope, fostering resilience, and promoting a culture of well-being that transcends borders. We are dedicated to pioneering a future where the power of neuromodulation transforms lives, creating a healthier, happier, and more connected global community." tVNS Health GmbH Headquarter Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health Contact tVNS Health info@tvns.health Contact Form

< Back Gadget review: release of new Airy Pods Daniel Williams Mar 21, 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. This is placeholder text. To change this content, double-click on the element and click Change Content. Want to view and manage all your collections? Click on the Content Manager button in the Add panel on the left. Here, you can make changes to your content, add new fields, create dynamic pages and more. Your collection is already set up for you with fields and content. Add your own content or import it from a CSV file. Add fields for any type of content you want to display, such as rich text, images, and videos. Be sure to click Sync after making changes in a collection, so visitors can see your newest content on your live site. Previous Next

tVNS Health Services and Solutions: At tVNS Health GmbH, we offer distinctive solutions and services tailored for the tVNS device ecosystem. Our expertise includes training healthcare professionals and organizations in the essentials of the therapy and device operation. Additionally, we extend online training and personalized therapy tracking services to patients and their families. This ensures the proper utilization of the devices, maximizing the benefits derived from this innovative technology. With a passion for solving unmet needs, we bring together technology, neuromodulation expertise and leading opinion leaders to create never-before-seen solutions. tVNS® Academy Training Our tVNS Training Services are designed to support patients as they begin their journey with transcutaneous vagus nerve stimulation (tVNS). We offer personalized, 1-on-1 training sessions tailored to individual needs, providing patients with expert guidance every step of the way. Access a range of online training materials and connect with a dedicated therapy consultant fluent in multiple languages for continuous support and assistance, ensuring a smooth and effective therapy experience. Contact our team tVNS® Care Services Our online tracking services aim patients achieve optimal results by accurately monitoring therapy, verifying the device utilization and compliance to the therapy plan. In addition, we offer access to a network of physicians experienced in transcutaneous vagus nerve neuromodulation therapy, providing professional consultation and guidance tailored to each patient's needs. Contact our team tVNS® Rental Services For doctors and patients interested in experiencing the benefits of our device before making a purchase, we offer customized rental service for different requirements and indications. Check the availability of this service in your country to start your trial today. Contact our team Request for Information

tVNS non-surgical, drug-free treatment with low side effects. The most up-to-date health information on the causes, symptoms, and treatment options of depression. Gain more freedom and self-determination. Treat depression with tVNS®. Depression Depression is a mood disorder that negatively affects the way one thinks and feels, interfering with one’s daily activities. It is characterized by a p ersistent feeling of sadness and hopelessness along with a loss of interest in activities that were once enjoyed. Treatment Options for Depression Medication There are different types of medications that can be used to treat depression including serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), Monoamine Oxidase Inhibitors (MAOIs), tricyclic and tetracyclic antidepressants, and many others. The doctor or pharmacist will inform patients about the possible mild or severe side effects of these drugs upon prescription, which will be followed by close monitoring for the first few weeks after starting the medication. Psychotherapy Psychotherapy is a general term for continuing treatment of depression which entails talking to a mental health professional about one’s condition and related issues. Psychotherapy is also known as talk therapy or psychological therapy. Different types of psychotherapy, such as cognitive behavioral therapy or trauma therapy, can be effective for depression depending on the patient. Hospital Treatment Some cases of severe depression requir e in-patient hospital stays. This may be necessary when the individual is unable to properly care for themselves and is in danger of harming themselves or others. Psychiatric treatment in a hospital can help an individual stay calm and safe until their mood improves. Partial hospital or day treatment programs may also help some individuals. Electroconvulsive therapy (ECT) In EC T, electrical currents are passed through the brain to impact the function and effect of neurotransmitters in your brain to relieve depression. ECT is usually used for people who don’t get better with medications, can’t take antidepressants for health reasons, or are at high risk of suicide. Transcranial magnetic stimulation (TMS) TMS may be an option for those who haven’t responded to antidepressants. During TMS, a treatment coil, placed against your scalp, sends brief magnetic pulses to stimulate nerve cells in your brain that are involved in mood regulation and depression. Transcutaneous Vagus Nerve Stimulation (tVNS) The tVNS® auricular vagus stimulation device is a treatment option that provides vagus nerve stimulation through the ear. The increase in parasympathetic activity from the stimulation provides relaxation and a calming effect. The increased release of serotonin provides a positive change in mood and the increased sleep quality leads to an improvement in the overall quality of life. Significant decreases in Hamilton Rating Scale for Depression, increase in Resting State Functional Connectivity and decrease in Beck Depression Inventory can be observed. tVNS® has very low side effects compared to drug options. tVNS® has helped many patients suffering from depression to reduce or completely eliminate their symptoms and lead a more self-determined and free life. Contact Us

tVNS non-surgical tvns treatment for cognitive impairment, dementia and alzheimer's. The most up-to-date health information on cognitive impairment causes, symptoms, and treatment options Cognitive Impairment Groundbreaking Technologies for Life What is Cognitive Impairment? The shrinkage caused by the loss of cells in the brain causes various functional disorders. These dysfunctions may manifest as dementia, Alzheimer, and mild cognitive impairment, which are comm on in people ives. People with cognitive impairment are at high risk for Alzheimer and dementia. When adequate precautions are taken, cognitive impairment may regress, and it is possible for these people to lead a normal life. Types of Cognitive Disorder Demantia It is the inadequacies experienced in language, skills and orientation, especially forgetfulness. Dementia is a family that includes many different types. There are Alzheimer's, dementia due to c hronic cerebrovascular disease, alcoholic dementia, depr essive dementia, dementia due to infections, etc. Dementia occurs as a result of general deterioration of the upper level functions of the cerebral cortex, especially over 75 years of age, with advancing age. There are dementias that start with memory impairment such as Alzheimer's disease, as well as behavioral disorders, skill disorders, depression, There are also dementias that start with the symptoms of parkinson's disease and language disorders. It is a progressive disease. Alzhemeir It is the most common type of dementia is a neurological disease that causes the destruction of brain cells. The disease, which causes a decrease in thought, memory and behavioral functions, occurs after a long time with advancing age. It may take years for the disease to reach advanced stages. Because it is a progressive disease, Alzheimer's patients experience problems such as inability to perform their daily tasks, forgetfulness and serious confusion. People with memory loss or other possible Alzheimer's symptoms may have trouble recognizing that they have a problem. Treatment Options for Cognitive Disorder There is no drug therapy approved to treat cognitive impairment. Medicines used to treat symptoms of Alzheimer's disease have been tried. Some studies have found that using these drugs for cognitive impairment is helpful, while others have concluded that there is no benefit. It has been noted that the use of other drugs, including NSAIDs, Ginkgo, Biloba and vitamin E, does not provide a great benefit. tVNS Effect Mechanism There are many clinical studies in recent years that cognitive disorders are caused by inflammation in the brain. Although the basic efficacy mechanism of tVNS has not been fully resolved, our new generation devices in 2021 became the first neuromodulation therapy approved for cognitive impairment in the world, due to both its benefits in the treatment of inflammation and the increase in neuroplasticity. Contact us

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. tVNS® in Italy: tVNS Health GmbH | E. M. S. s. r. l tVNS Health GmbH is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients’ quality of life. E.M.S. s.r.l. is a commercial company founded in Bologna in 1994 and ISO-9001 certified. Specializing in the marketing of electromedical equipment and related software systems, the company has established itself as a reliable partner in the field of medical technology. With deep expertise in neuropsychology, neurology, neurorehabilitation, and neurosurgery, E.M.S. offers high-quality, innovative, and exclusive solutions. Thanks to its strong sales network and advanced organizational structure, the company serves both hospitals and neurophysiological research centers with products that exceed standard market quality. In Italy, E.M.S. s.r.l. is the official distributor of tVNS Health GmbH and tVNS Technologies GmbH , providing sales and support services for tVNS® devices and ensuring widespread access to neuromodulation treatments. tVNS Health GmbH Global Sales & Services: Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health E. M. S. s. r. l Distributor in Italy Via di Saliceto 81, 40128 Bologna Italy www.emsmedical.net Tel. +39-051396205 Contact Us

Drug-free non-surgical tvns vagal nerve stimulation in the treatment of tinnitus. The most up-to-date health information on tinnitus causes, symptoms, treatment options Tinnitus Tinnitus and Vagus Nerve Stimulation Tinnitus can also be defined as the patient's perception of a sound without an acoustic stimulus. This sound can have different tones, features and characters. The sound most often heard as ringing is sometimes described as humming, bells, wind or whistling, machinery noise, rustling, pulsing sounds. Tinnitus is considered as a symptom rather than a disease and is treated as such. It is the most common symptom of the auditory system. These complaints may be severe enough to cause mental problems or severely impair the quality of life, and in some people, tinnitus may come and go within a few minutes. Clinical studies have shown that vagus nerve stimulation provides an increase in parasympathetic activity, calms the patient, reduces sleep disorders due to tinnitus, and decreases THI (Tinnitus Handicap Inventoy). For more detailed information, please contact tVNS Turkey. Contact us

tVNS, non-surgical treatment option for epilepsy. The most up-to-date health information about epilepsy causes, symptoms, treatment options Less seizures - more from life. Treat drug-resistant epilepsy wit h tVNS® Epilepsy An epileptic seizure is a clinical condition that occurs when the normal activity of the brain is disrupted by the temporary abnormal electrical acti vity in the nerve cells. Epilepsy is the recurrence of epileptic seizures and is considered a chronic disease. While anticonvulsants are commonly prescribed, many epileptic patients are resist ant to drug therapy. Treatment Options for Drug Resistant Epilepsy Epilepsy Surgery There are two methods of neurosurgery: removal of the brain region that causes seizures and surgical cutting of the neural pathways that cause seizures to spread. However, since these methods are only suitable for focal epilepsies, only a small proportion of epilepsy patients are suitable for this invasive procedure. In deep brain stimulation, electrodes are implanted in the brain. These electrodes are attached to a battery operated stimulator that is usually placed under the patient’s collarbone. Epileptic activity can be specifically affected at the baseline through current stimuli. Deep Brain Stimulation Invasive Vagus Nerve Stimulation In some patients, a treatment called “vagus nerve stimulation”, also known as brain pacemaker surgery, can be applied. With a surgical intervention, a battery is placed under the chest and an electrode wire is placed in the vagus nerve in the neck. With the help of the electrode, the vagus nerve is stimulated at regular intervals, which may reduce seizures. Transcutaneous Vagus Nerve Stimulation The tVNS® auricular vagus nerve stimulation device is a treatment option that provides vagus nerve stimulation through the ear with a smartphone-sized device and a special headset without any surgical intervention. From there, as with invasive vagus nerve stimulation, higher centers of the brain are activated, triggering an anticonvulsant effect. How does tVNS® treat epilepsy? In transcutaneous vagus nerve stimulation, mild electrical impulses are given to the cymba concha region in the outer auricle through a special ear electrode. These stimuli activate the vagus nerve, which passes directly under the skin in this region (auricular branch of the vagus nerve). The nerve first transmits these impuleses to the Nucleus Tractus Solitarius in the brain stem and are transmitted to many different regions of the diencephalon (midbrain) and cerebrum. These stimuli are also transmitted to the Norepinephrine (Noradrenaline) center, the Locus Coeruleus, and Serotonin center, the Dorsal Raphe nucleus. These transmitters affect one’s clarity, energy, and confidence. These 2 centers send these neurotransmitters to the entire brain, specifically to the parts that control thinking and feeling. more serotonin and norepinephrine are then sent to the Prefrontal Cortex and are inhibited in the Hippocampus and Anterior Thalamus regions, which reduces anxiety and panic. This mechanism causes the frequency or severity of seizures to be reduced or stopped entirely. tVNS has helped hundreds of patients suffering from epilepsy to reduce or completely eliminate their seizures and lead a more self-determined life, without the need for surgery. “It’s wonderful that with tVNS® I have found a therapy option that makes me feel better without needing surgery.” Katja S. from Munich